-
2
-
-
40549093007
-
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen)
-
Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy 2008: 63 (Suppl 86): 8-160.
-
(2008)
Allergy
, vol.63
, Issue.SUPPL. 86
, pp. 8-160
-
-
Bousquet, J.1
Khaltaev, N.2
Cruz, A.A.3
-
3
-
-
0031817107
-
Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997
-
Bousquet J, Lockey RF, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997. Allergy 1998: 44 (Suppl): 1-42.
-
(1998)
Allergy
, vol.44
, Issue.SUPPL.
, pp. 1-42
-
-
Bousquet, J.1
Lockey, R.F.2
Malling, H.J.3
-
4
-
-
12444291506
-
Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis
-
Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005: 60: 4-12.
-
(2005)
Allergy
, vol.60
, pp. 4-12
-
-
Wilson, D.R.1
Lima, M.T.2
Durham, S.R.3
-
5
-
-
33747688429
-
Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials
-
Penagos M, Compalati E, Tarantini F, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006: 97: 141-8.
-
(2006)
Ann Allergy Asthma Immunol
, vol.97
, pp. 141-148
-
-
Penagos, M.1
Compalati, E.2
Tarantini, F.3
-
7
-
-
0347302914
-
Allergic rhinitis: a disease remodeling the upper airways?
-
Bousquet J, Jacot W, Vignola AM, Bachert C, Van Cauwenberge P. Allergic rhinitis: a disease remodeling the upper airways? J Allergy Clin Immunol 2004: 113: 43-9.
-
(2004)
J Allergy Clin Immunol
, vol.113
, pp. 43-49
-
-
Bousquet, J.1
Jacot, W.2
Vignola, A.M.3
Bachert, C.4
Van Cauwenberge, P.5
-
8
-
-
1142273302
-
Allergic rhinitis, rhinosinusitis, and asthma: one airway disease
-
Bachert C, Vignola AM, Gevaert P, Leynaert B, Van Cauwenberge P, Bousquet J. Allergic rhinitis, rhinosinusitis, and asthma: one airway disease. Immunol Allergy Clin North Am 2004: 24: 19-43.
-
(2004)
Immunol Allergy Clin North Am
, vol.24
, pp. 19-43
-
-
Bachert, C.1
Vignola, A.M.2
Gevaert, P.3
Leynaert, B.4
Van Cauwenberge, P.5
Bousquet, J.6
-
9
-
-
0028842683
-
Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study
-
Feliziani V, Lattuada G, Parmiani S, Dall'Aglio PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Allergol Immunopathol (Madr) 1995: 23: 224-30.
-
(1995)
Allergol Immunopathol (Madr)
, vol.23
, pp. 224-230
-
-
Feliziani, V.1
Lattuada, G.2
Parmiani, S.3
Dall'Aglio, P.P.4
-
10
-
-
21244500177
-
Safety and tolerability of ultra-rush (20 minutes) sublingual immunotherapy in patients with allergic rhinitis and/or asthma
-
Gammeri E, Arena A, D'Anneo R, La Grutta S. Safety and tolerability of ultra-rush (20 minutes) sublingual immunotherapy in patients with allergic rhinitis and/or asthma. Allergol Immunopathol (Madr) 2005: 33: 221-3.
-
(2005)
Allergol Immunopathol (Madr)
, vol.33
, pp. 221-223
-
-
Gammeri, E.1
Arena, A.2
D'Anneo, R.3
La Grutta, S.4
-
11
-
-
31744442578
-
Safety and tolerability of ultra-rush induction, less than one hour, of sublingual immunotherapy in children
-
Tripodi S, Di Rienzo Businco A, Benincori N, Scala G, Pingitore G. Safety and tolerability of ultra-rush induction, less than one hour, of sublingual immunotherapy in children. Int Arch Allergy Immunol 2006: 139: 149-52.
-
(2006)
Int Arch Allergy Immunol
, vol.139
, pp. 149-152
-
-
Tripodi, S.1
Di Rienzo Businco, A.2
Benincori, N.3
Scala, G.4
Pingitore, G.5
-
12
-
-
65249163373
-
Safety and tolerability of seasonal ultra-rush, high-dose sublingual-swallow immunotherapy in allergic rhinitis to grass and tree pollens: an observational study in 193 children and adolescents
-
Seidenberg J, Pajno GB, Bauer CP, La Grutta S, Sieber J. Safety and tolerability of seasonal ultra-rush, high-dose sublingual-swallow immunotherapy in allergic rhinitis to grass and tree pollens: an observational study in 193 children and adolescents. J Investig Allergol Clin Immunol 2009: 19: 125-31.
-
(2009)
J Investig Allergol Clin Immunol
, vol.19
, pp. 125-131
-
-
Seidenberg, J.1
Pajno, G.B.2
Bauer, C.P.3
La Grutta, S.4
Sieber, J.5
-
13
-
-
79959344460
-
Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007
-
Expert Panel Report 3 (EPR-3)
-
Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007;120(5 Suppl):S94-138.
-
(2007)
J Allergy Clin Immunol
, vol.120
, Issue.5 SUPPL.
-
-
-
14
-
-
0031864005
-
Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis
-
Clavel R, Bousquet J, André C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 1998: 53: 493-8.
-
(1998)
Allergy
, vol.53
, pp. 493-498
-
-
Clavel, R.1
Bousquet, J.2
André, C.3
|